沈雳,李晨光,吴轶喆,裴志强,葛均波

• 1:复旦大学附属中山医院心内科上海市心血管病研究所国家放射与治疗临床医学研究中心上海市放射与治疗(介入治疗)临床医学研究中心

摘要(Abstract)：

<正>创新是时代永恒的主题。在创新驱动和高质量发展的背景下，一系列支持医学创新的政策相继推出，医学创新迎来最好的发展时代。作为中国医学创新的缩影，中国心血管医疗器械经过四十余年的发展，也逐步从早期的学习与跟随进入到自主创新的快速发展时期，在部分领域已达到世界先进水平，为中国的心血管病防治和健康中国建设提供了有力支撑。

关键词(KeyWords)： 数字减影血管造影;光学相干断层成像;血管内超声;血流储备分数;支架;球囊;起搏器;消融设备;瓣膜;封堵器

Abstract:

Keywords:

基金项目(Foundation): 上海市放射与治疗（介入治疗）临床医学研究中心项目（19MC1910300）

作者(Author): 沈雳,李晨光,吴轶喆,裴志强,葛均波

参考文献(References)：

• [1] Gonzalez JA, Lipinski MJ, Flors L, et al. Meta-analysis of diagnostic performance of coronary computed tomography angiography, computed tomography perfusion, and computed tomographyfractional flow reserve in functional myocardial ischemia assessment versus invasive fractional fl ow reserve[J].Am J Cardiol,2015,116(9):1469-1478.
• [2] Douglas PS, Pontone G, Hlatky MA, et al. Clinical outcomes of fractional fl ow reserve by computed tomographic angiography guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease:the prospective longitudinal trial of FFRCT:outcome and resource impacts study[J]. Eur Heart J,2015,36(47):3359-3367.
• [3] Kashiwagi M, Tanaka A, Kitabata H, et al. Feasibility of noninvasive computed tomography angiography, computed tomography perfusion, and computed tomographyfractional fl ow reserve in functional myocardial ischemia assessment versus invasive fractional fl ow reserve[J]. Am J Cardiol,2015,116(9):1469-1478.
• [4] Nakazato R,Otake H, Konishi A, et al. Atherosclerotic plaque characterization by CT angiography for identification of highrisk coronary artery lesions:a comparison to optical coherence tomography[J]. Eur Heart J Cardiovasc Imaging,2015,16(4):373-379.
• [5] Opolski MP, Achenbach S. CT Angiography for revascularization of CTO:crossing the borders of diagnosis and treatment[J].JACC Cardiovasc Imaging,2015,8(7):846-858.
• [6] Opolski MP, Achenbach S, Schuhback A, et al. Coronary computed tomographic prediction rule for time-e ffi cient guidewire crossing through chronic total occlusion:insights from the CTRECTOR multicenter registry(Computed Tomography Registry of Chronic Total Occlusion Revascularization)[J].JACC Cardiovasc Interv,2015,8(2):257-267.
• [7] Onuma Y, Dudek D, Thuesen L, et al. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease:the ABSORB cohort A trial[J]. JACC Cardiovasc Interv,2013,6(10):999-1009.
• [8] Chatzizisis YS, George E, Cai T, et al. Accuracy and reproducibility of automated, standardized coronary transluminal attenuation gradient measurements[J]. Int J Cardiovasc Imaging,2014,30(6):1181-1189.
• [9] Wong DT, Ko BS, Cameron JD, et al. Transluminal attenuation gradient in coronary computed tomography angiography is a novel noninvasive approach to the identifi cation of functionally signifi cant coronary artery stenosis:a comparison with fractional fl ow reserve[J]. J Am Coll Cardiol,2013,61(12):1271-1279.
• [10] Zorach B, Shaw PW, Bourque J, et al. Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease[J]. J Cardiovasc Magn Reson,2018,20(1):14.
• [11] Vermes E, Carbone I, Friedrich MG, et al. Patterns of myocardial late enhancement:typical and atypical features[J].Arch Cardiovasc Dis,2012,105(5):300-308.
• [12] Mayala HA, Bakari KH, Zhaohui W. The role of cardiac magnetic resonance(CMR)in the diagnosis of cardiomyopathy:a systematic review[J]. Malawi Med J,2018,30(4):291-295.
• [13] Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantifi cation:a Society for Cardiovascular Magnetic Resonance(SCMR)and CMR Working Group of the European Society of Cardiology consensus statement[J]. J Cardiovasc Magn Reson,2013,15(1):92.
• [14] Nayak KS, Nielsen JF, Bernstein MA, et al. Cardiovascular magnetic resonance phase contrast imaging[J]. J Cardiovasc Magn Reson,2015,17(1):71.
• [15] Smilowitz NR, Mohananey D, Razzouk L, et al. Impact and trends of intravascular imaging in diagnostic coronary angiography and percutaneous coronary intervention in inpatients in the United States[J]. Catheter Cardiovasc Interv,2018,92(6):E410-E415.
• [16] Chieffo A, Latib A, Caussin C, et al. A prospective,randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions:the AVIO trial[J]. Am Heart J,2013,165(1):65-72.
• [17] Ali ZA, Maehara A, Généreux P, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation(ILUMIENⅢ：OPTIMIZE PCI):a randomised controlled trial[J].Lancet, 2016,388(10060):2618-2628.
• [18] Witzenbichler B, Maehara A, Weisz G, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents:the assessment of dual antiplatelet therapy with drug-eluting stents(ADAPT-DES)study[J].Circulation,2014,129(4):463-470.
• [19] Liu X, Doi H, Maehara A, et al. A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis[J]. JACC Cardiovasc Interv,2009,2(5):428-434.
• [20] Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation:an intravascular ultrasound study[J]. J Am Coll Cardiol,2005,45(7):995-998.
• [21] Kang SJ, Ahn JM, Song H, et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease[J]. Circ Cardiovasc Interv,2011,4(6):562-569.
• [22] Prati F, Romagnoli E, Burzotta F, et al. Clinical impact of OCT findings during PCI:the CLIOPCI II study[J]. JACC Cardiovasc Imaging,2015,8(11):1297-1305.
• [23] Soeda T, Uemura S, Park SJ, et al. Incidence and clinical signifi cance of poststent optical coherence tomography fi ndings:one-year follow-up study from a multicenter registry[J].Circulation,2015,132(11):1020-1029.
• [24] Qiu F, Mintz GS, Witzenbichler B, et al. Prevalence and clinical impact of tissue protrusion after stent implantation:an ADAPT-DES intravascular ultrasound substudy[J]. J Am Coll Cardiol Intv,2016,9(14):1499-1507.
• [25] Im E, Kim BK, Ko YG, et al. Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation[J]. Circ Cardiovasc Interv,2014,7(1):88-96.
• [26] Goto K, Zhao Z, Matsumura M, et al. Mechanisms and patterns of intravascular ultrasound instent restenosis among bare metal stents and fi rst-and second-generation drug-eluting stents[J]. Am J Cardiol,2015,116(9):1351-1357.
• [27] Song L, Mintz GS, Yin D, et al. Characteristics of e a r l y versus late in-stent restenosis in second-generation drugeluting stents:an optical coherence tomography study[J].EuroIntervention,2017,13(3):294-302.
• [28] Sheth TN, Pinilla-Echeverri N, Mehta SR, et al. Firstin-human images of coronary atherosclerosis and coronary stents using a novel hybrid intravascular ultrasound and optical coherence tomographic catheter[J]. JACC Cardiovasc Interv,2018,11(23):2427-2430.
• [29] Muller J, Madder R. OCT-NIRS imaging for detection of coronary plaque structure and vulnerability[J]. Front Cardiovasc Med,2020,7:90.
• [30] Waksman R, Di Mario C, Torguson R, et al. Identifi cation of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging:a prospective, cohort study[J]. Lancet,2019,394(10209):1629-1637.
• [31] Nishimiya K, Tearney G. Micro optical coherence tomography for coronary imaging[J]. Front Cardiovasc Med,2021,8:613400.
• [32] Pijls NH, van Schaardenburgh P, Manoharan G, et al.Percutaneous coronary intervention of functionally nonsignifi cant stenosis:5-year follow-up of the DEFER study[J]. J Am Coll Cardiol,2007,49(21):2105-2111.
• [33] Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease:2-year followup of the FAME(fractional flow reserve versus angiography for multivessel evaluation)study[J]. J Am Coll Cardiol,2010,56(3):177-184.
• [34] De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve guided PCI versus medical therapy in stable coronary disease[J]. N Engl J Med,2012,367(11):991-1001.
• [35] Berry C, Layland J, Stood A, et al. Fractional flow reserve versus angiography in guiding management to optimize outcomes in non-ST-elevation myocardial infarction(FAMOUSNSTEMI):rationale and design of a randomized controlled clinical trial[J]. Am Heart J,2013,166(4):662-668.
• [36] Engstr?m T, Kelb?k H, Helqvist S, et al. Complete revascularization versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease(DANAMI-3-PRIMULTI):an openlabel, randomized controlled trial[J]. Lancet,2015,386(9994):665-671.
• [37] Smits PC, Abdel-Wahab M, Neumann FJ, et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction[J]. N Engl J Med,2017,376(13):1234-1244.
• [38] Li C, Yang J, Dong S, et al. Multicenter clinical evaluation of a piezoresistive-MEMS-sensor rapid-exchange pressure m i c r o c a t h e t e r s y s t e m f o r f r a c t i o n a l f l o w r e s e r v e measurement[J]. Catheter Cardiovasc Interv,2021,98(2):E243-E253.
• [39] Davies JE, Sen S, Dehbi HM, et al. Use of the instantaneous wave-free ratio or fractional fl ow reserve in PCI[J]. N Engl J Med,2017,376(19):1824-1834.
• [40] Escaned J, Ryan N, Mejía-Rentería H, et al. Safety of the deferral of coronary revascularization on the basis of instantaneous wave-free ratio and fractional fl ow reserve measurements in stable coronary artery disease and acute coronary syndromes[J].JACC Cardiovasc Interv,2018,11(15):1437-1449.
• [41] Svanerud J, Ahn JM, Jeremias A, et al. Validation of a novel non-hyperaemic index of coronary artery stenosis severity:the Resting Full-cycle Ratio(VALIDATE RFR)study[J].EuroIntervention,2018,14(7):806-814.
• [42] Tu S, Westra J, Adjedj J, et al. Fractional flow reserve in clinical practice:from wire-based invasive measurement to image-based computation[J]. Eur Heart J,2020,41(34):3271-3279.
• [43] Xu B, Tu S, Qiao S, et al. Diagnostic accuracy o f angiography-based quantitative flow ratio measurements for online assessment of coronary stenosis[J]. J Am Coll Cardiol,2017,70(25):3077-3087.
• [44] Li J, Gong Y, Wang W, et al. Accuracy of computational pressure-fl uid dynamics applied to coronary angiography to derive fractional flow reserve:FLASH FFR[J]. Cardiovasc Res,2020,116(7):1349-1356.
• [45] Ai H, Zheng N, Li L, et al. Agreement of angiographyderived and wire-based fractional fl ow reserves in percutaneous coronary intervention[J]. Front Cardiovasc Med,2021,8:654392.
• [46] Granada JF, Delgado JA, Uribe MP, et al. First-in-human evaluation of a novel robotic-assisted coronary angioplasty system[J]. JACC Cardiovasc Interv,2011,4(4):460-465.
• [47]赵玉玲. 2020中国心血管介入器械行业研究报告[EB/OL].(2020-09-18)[2022-02-05]. http：//pg. jrj. com. cn/acc/Res/CN_RES/INDUS/2020/9/18/716b6bel-e7f6-4f45-89fd-5d4b7b2dc6f0. pdf.